Persephone Biosciences

About:

Persephone Biosciences uses artificial intelligence to rapidly develop microbial based immunotherapies to enable a lifetime without cancer.

Website: https://www.persephonebiosciences.com

Twitter/X: persephonebio

Top Investors: Y Combinator, Fifty Years, Pioneer Fund, Susa Ventures, ZhenFund

Description:

Persephone Biosciences develops healthcare technology designed to focus on microbial therapeutics for immuno-oncology applications. The company's technology uses artificial intelligence and omics techniques on multiple cancer patient gut microbiome and blood samples to identify microbes needed for normal immune function for population-scale patient data analytics, enabling lab researchers to design microbial drugs that prevent and fight cancer. Persephone Biosciences was founded in 2017 and is based in San Diego, California.

Total Funding Amount:

$15.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2017-01-01

Founders:

Stephanie Culler, Steve Van Dien

Number of Employees:

11-50

Last Funding Date:

2022-07-19

IPO Status:

Private

© 2024 MyAiNote.com